NUR 202 - Nursing Through the Lifespan II

Nursing Through the Lifespan IINUR 202

Module D

COURSE TITLE: /

NUR 202 – Nursing Through the Lifespan II

MODULE: / D – Immune System Alterations
RECOMMENDED TIMEFRAME: / 7 hours / Effective Date / 7-24-06
A. Instructor Preparation
1.Materials/Supplies Requirements:
2.Audiovisual Requirements

3.Equipment Requirements

4.Handouts/Supplemental Materials

5.Classroom/Lab/Clinical Set Up Requirements

6.Suggested References

7.Evaluation Methodology

8. Clinical/Lab Skills:

Critical thinking skills
Use of relevant technology for client care and documentation
Interpret diagnostic data
Teaching/learning plan
Assist with treatment modalities
Administer medications
Advanced dosage calculations

Adhere to policies and safety requirements

The AlabamaCollege System

Nursing Through the Lifespan IINUR 202

Module D

B. Suggested Presentation Methods
1. Competencies and Objectives
Competency / Student Performance Objectives
D1.0 / Provide nursing care for clients experiencing selected immune system alterations. / D1.1 / Apply the nursing process for clients experiencing selected immune system alterations.
Instructor Notes:
b. Suggested Presentation Methods
2. LEARNING Objectives
D1.1.1Define terms associated with selected immune system alterations.
D1.1.2Describe selected immune system alterations.
D1.1.3Describe the pathophysiology for selected immune system alterations.
D1.1.4Describe the role of the nurse in providing care for clients experiencing selected immune system alterations.
D1.1.5Explain health promotion related to the immune system.
D1.1.6Interpret clinical manifestations for immune system alterations.
D1.1.7Interpret diagnostic tests for selected immune system alterations.
D1.1.8Describe the pharmacological agents and/or treatments for selected immune alterations.
D1.1.9Evaluate nutritional considerations for clients experiencing selected immune alterations.
D1.1.10Identify expected outcomes of treatment modalities for clients experiencing selected immune system alterations.
D1.1.11Evaluate psychosocial needs of clients, families, and/or support systems.
D1.1.12Use critical thinking to manage care for culturally diverse clients experiencing selected immune system alterations.
D1.1.13Evaluate expected outcomes of nursing care for clients experiencing selected immune system alterations.
D1.1.14Assess the impact of selected immune system alterations on maternal and pediatric clients.
Instructor Notes:
D. Lesson Development
Theory = T
Lab = L
Clinicals = C / Main Points
T / L / C
T / 1.0Review
1.1Immune Response
1.2Immune System organs
1.2.1B Lymphocytes
1.2.2T Lymphocytes
1.3Types of Immunity
1.3.1Humeral
1.3.2Cell Mediator
1.4Autoimmunity
1.5Health Promotion and Risk Management
1.6Infectious Process
1.6.1Stages of infectious diseases
1.6.2Chain of infection
1.6.3Health Promotion and Risk Management
T / C / 2.0Pediatrics
2.1Immunodeficiency Disorders
2.1.1Congenital Immunodeficiency
2.1.2Acquired Immunodeficiency
2.1.2.1AIDS/HIV

Transmission
Assessment
Medical Management
Application of the nursing process

2.2Allergies
2.2.1Hypersensitivity
2.2.2Assessment
2.2.3Diagnostic Testing
2.2.4Medical Management
2.2.5Pharmacological Therapy
2.2.6Common Immune Reactions
2.2.6.1Uticaria and Angioedema
2.2.6.2Serum Sickness
2.2.7Drug and Food Allergies
2.3Infectious Diseases
T / 2.3.3Viral Infections
2.3.3.1Herpes Zoster
2.3.3.2Pityriasis Rosea
2.4Enteroviruses
2.4.1Echo virus
2.4.2Coxsackievirus
2.4.3Polio
2.5Viral Infections of the integumentary system
2.5.1Herpes
2.5.2Verrucae (warts)
2.6Virus causes Central Nervous Disease
2.7Rabies
2.8Hantavirus
2.9Bacterial Infections
2.9.1Streptococcal
2.9.1.1Scarlet Fever
2.9.1.2Cat Scratch Disease
2.9.2Staphylococcal
2.9.2.1Scalded skin
2.9.3Other
2.9.3.1Diphtheria
2.9.3.2Tetanus
2.9.3.3Lyme Disease
2.10Other Infectious Pathogens
2.10.1Rickettsial Diseases
2.11Protazoans
2.12Fungal Infections
2.13.1Candidiasis
2.13Application of the nursing process
T / C
C / 3.0Adult
3.1Autoimmune Diseases
3.1.1Systemic Lupus Erythematous
3.1.1.1Pathophysiology
3.1.1.2Clinical Manifestations
3.1.1.3Diagnostic Tests
3.1.1.4Treatment

Medical Management
Pharmacologic Agents
Nutritional Considerations

3.1.2Application of the nursing process
3.2Hypersensitivity
3.2.1Types
3.2.1.1Anaphylaxsis
3.2.1.2Latex Allergies
3.2.1.3Food and Drug Allergies
3.2.2Pathophysiology
3.2.2.1Clinical Manifestations
3.2.2.2Diagnostic Tests
3.2.2.3Treatment

Medical Management
Pharmacologic Agents
Nutritional Considerations

3.2.3Application of the nursing process
3.3HIV/AIDS
3.3.1Pathophysiology
3.3.2Modes of Transmission
3.3.2.1Sexual
3.3.2.2Parenteral
3.3.2.3Perinatal
3.3.3Types
3.3.4Clinical Manifestations
3.3.5Diagnostic Testing
3.3.5.1T-Cell
3.3.5.2Viral Load
3.3.5.3Western Blot
3.3.5.4HIV RNA-DNA
3.3.5.5ELISA
T / C
C / 3.4Opportunistic Infections
3.4.1Candida Albicans
3.4.2Pneumocystic Carinii Pneumonia
3.4.3Cytomegalovirus
3.4.4Kaposi’s Sarcoma
3.4.5Treatment Modalities
3.4.5.1Pharmacologic Agents
3.4.5.2Nutritional Considerations
3.4.6Life-style considerations
3.4.6.1Exercise
3.4.6.2Stress Reduction
3.4.6.3Smoking Cessation
3.4.6.4Sexual Practices
3.4.6.5Alcohol and Drug Use
3.4.7Application of the nursing process
3.5Emerging Infections
3.5.1Types
3.5.2West Nile
3.5.3Legionnaire’s
3.5.4Lyme Disease
3.5.5Ebola and Marburg (Filoviruses)
3.5.6SARS
3.5.7Avian Influenza
3.5.8Diarrheal Diseases

Shigella
Campylobacter
Giardia Lamblia
Vibrio Cholera

3.5.2Pathophysiology
3.5.3Clinical Manifestations
3.5.4Diagnostic Tests
3.5.5Treatment
3.5.5.1Medical Management
3.5.5.2Pharmacologic Agents
3.5.5.3Nutritional Considerations
3.5.6Application of the nursing process
T / C / 3.6Nosocomial Infections
3.6.1Types
3.6.1.1Clostridium Difficel
3.6.1.2Methocillin Resistant Staphlococcal Aureous
3.6.1.3Vancomycin Resistant Enterococcus
3.6.2Pathophysiology
3.6.3Clinical Manifestations
3.6.4Diagnostic Tests
3.6.5Treatment
3.6.5.1Medical Management
3.6.5.2Pharmacologic Agents
3.6.5.3Nutritional Considerations
3.6.6Application of the nursing process
E. Assignments AND DUE DATES
F. sUMMARY AND REVIEW